A Secret Weapon For Xevinapant
123). It really is notable that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for lack of Gls in MYC-induced mouse liver tumours40. This suggests that GLS2 could confer resistance to GLS1-certain inhibitors, including the allosteric inhibitor BPTES or CB-839, which resistance could possibly be hypothetically averted b